Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling

Regina G. Weiss, Kristen M S O'Connell, Bernhard E. Flucher, Paul D. Allen, Manfred Grabner, Robert T. Dirksen

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Malignant hyperthermia (MH) is an inherited pharmacogenetic disorder caused by mutations in the skeletal muscle ryanodine receptor (RyR1) and the dihydropyridine receptor (DHPR) α1S-subunit. We characterized the effects of an MH mutation in the DHPR cytoplasmic III-IV loop of α1S (R1086H) on DHPR-RyR1 coupling after reconstitution in dysgenic (α1S null) myotubes. Compared with wild-type α1S, caffeine-activated Ca2+ release occurred at approximately fivefold lower concentrations in nonexpressing and R1086H-expressing myotubes. Although maximal voltage-gated Ca2+ release was similar in α1S- and R1086H-expressing myotubes, the voltage dependence of Ca2+ release was shifted ∼5 mV to more negative potentials in R1086H-expressing myotubes. Our results demonstrate that α1S functions as a negative allosteric modulator of release channel activation by caffeine/voltage and that the R1086H MH mutation in the intracellular III-IV linker disrupts this negative regulatory influence. Moreover, a low caffeine concentration (2 mM) caused a similar shift in voltage dependence of Ca2+ release in α1S- and R1086H-expressing myotubes. Compared with α1S-expressing myotubes, maximal L channel conductance (Gmax) was reduced in R1086H-expressing myotubes (α1S 130 ± 10.2, R1086H 88 ± 6.8 nS/nF; P < 0.05). The decrease in Gmax did not result from a change in retrograde coupling with RyR1 as maximal conductance-charge movement ratio (Gmax/Qmax) was similar in α1S- and R1086H-expressing myotubes and a similar decrease in Gmax was observed for an analogous mutation engineered into the cardiac L channel (R1217H). In addition, both R1086H and R1217H DHPRs targeted normally and colocalized with RyR1 in sarcoplasmic reticulum (SR)-sarcolemmal junctions. These results indicate that the R1086H MH mutation in α1S enhances RyR1 sensitivity to activation by both endogenous (voltage sensor) and exogenous (caffeine) activators.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Cell Physiology
Volume287
Issue number4 56-4
DOIs
StatePublished - Oct 2004
Externally publishedYes

Fingerprint

Malignant Hyperthermia
L-Type Calcium Channels
Functional analysis
Ryanodine Receptor Calcium Release Channel
Skeletal Muscle Fibers
Muscle
Skeletal Muscle
Caffeine
Mutation
Electric potential
Chemical activation
Modulators
Pharmacogenetics
Sarcoplasmic Reticulum
Sensors

Keywords

  • Calcium channel
  • Excitation-contraction coupling
  • Muscle disease

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling. / Weiss, Regina G.; O'Connell, Kristen M S; Flucher, Bernhard E.; Allen, Paul D.; Grabner, Manfred; Dirksen, Robert T.

In: American Journal of Physiology - Cell Physiology, Vol. 287, No. 4 56-4, 10.2004.

Research output: Contribution to journalArticle

Weiss, Regina G. ; O'Connell, Kristen M S ; Flucher, Bernhard E. ; Allen, Paul D. ; Grabner, Manfred ; Dirksen, Robert T. / Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling. In: American Journal of Physiology - Cell Physiology. 2004 ; Vol. 287, No. 4 56-4.
@article{5ec4c380192440bcac93b953b0ecb4f3,
title = "Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling",
abstract = "Malignant hyperthermia (MH) is an inherited pharmacogenetic disorder caused by mutations in the skeletal muscle ryanodine receptor (RyR1) and the dihydropyridine receptor (DHPR) α1S-subunit. We characterized the effects of an MH mutation in the DHPR cytoplasmic III-IV loop of α1S (R1086H) on DHPR-RyR1 coupling after reconstitution in dysgenic (α1S null) myotubes. Compared with wild-type α1S, caffeine-activated Ca2+ release occurred at approximately fivefold lower concentrations in nonexpressing and R1086H-expressing myotubes. Although maximal voltage-gated Ca2+ release was similar in α1S- and R1086H-expressing myotubes, the voltage dependence of Ca2+ release was shifted ∼5 mV to more negative potentials in R1086H-expressing myotubes. Our results demonstrate that α1S functions as a negative allosteric modulator of release channel activation by caffeine/voltage and that the R1086H MH mutation in the intracellular III-IV linker disrupts this negative regulatory influence. Moreover, a low caffeine concentration (2 mM) caused a similar shift in voltage dependence of Ca2+ release in α1S- and R1086H-expressing myotubes. Compared with α1S-expressing myotubes, maximal L channel conductance (Gmax) was reduced in R1086H-expressing myotubes (α1S 130 ± 10.2, R1086H 88 ± 6.8 nS/nF; P < 0.05). The decrease in Gmax did not result from a change in retrograde coupling with RyR1 as maximal conductance-charge movement ratio (Gmax/Qmax) was similar in α1S- and R1086H-expressing myotubes and a similar decrease in Gmax was observed for an analogous mutation engineered into the cardiac L channel (R1217H). In addition, both R1086H and R1217H DHPRs targeted normally and colocalized with RyR1 in sarcoplasmic reticulum (SR)-sarcolemmal junctions. These results indicate that the R1086H MH mutation in α1S enhances RyR1 sensitivity to activation by both endogenous (voltage sensor) and exogenous (caffeine) activators.",
keywords = "Calcium channel, Excitation-contraction coupling, Muscle disease",
author = "Weiss, {Regina G.} and O'Connell, {Kristen M S} and Flucher, {Bernhard E.} and Allen, {Paul D.} and Manfred Grabner and Dirksen, {Robert T.}",
year = "2004",
month = "10",
doi = "10.1152/ajpcell.00173.2004",
language = "English (US)",
volume = "287",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "4 56-4",

}

TY - JOUR

T1 - Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling

AU - Weiss, Regina G.

AU - O'Connell, Kristen M S

AU - Flucher, Bernhard E.

AU - Allen, Paul D.

AU - Grabner, Manfred

AU - Dirksen, Robert T.

PY - 2004/10

Y1 - 2004/10

N2 - Malignant hyperthermia (MH) is an inherited pharmacogenetic disorder caused by mutations in the skeletal muscle ryanodine receptor (RyR1) and the dihydropyridine receptor (DHPR) α1S-subunit. We characterized the effects of an MH mutation in the DHPR cytoplasmic III-IV loop of α1S (R1086H) on DHPR-RyR1 coupling after reconstitution in dysgenic (α1S null) myotubes. Compared with wild-type α1S, caffeine-activated Ca2+ release occurred at approximately fivefold lower concentrations in nonexpressing and R1086H-expressing myotubes. Although maximal voltage-gated Ca2+ release was similar in α1S- and R1086H-expressing myotubes, the voltage dependence of Ca2+ release was shifted ∼5 mV to more negative potentials in R1086H-expressing myotubes. Our results demonstrate that α1S functions as a negative allosteric modulator of release channel activation by caffeine/voltage and that the R1086H MH mutation in the intracellular III-IV linker disrupts this negative regulatory influence. Moreover, a low caffeine concentration (2 mM) caused a similar shift in voltage dependence of Ca2+ release in α1S- and R1086H-expressing myotubes. Compared with α1S-expressing myotubes, maximal L channel conductance (Gmax) was reduced in R1086H-expressing myotubes (α1S 130 ± 10.2, R1086H 88 ± 6.8 nS/nF; P < 0.05). The decrease in Gmax did not result from a change in retrograde coupling with RyR1 as maximal conductance-charge movement ratio (Gmax/Qmax) was similar in α1S- and R1086H-expressing myotubes and a similar decrease in Gmax was observed for an analogous mutation engineered into the cardiac L channel (R1217H). In addition, both R1086H and R1217H DHPRs targeted normally and colocalized with RyR1 in sarcoplasmic reticulum (SR)-sarcolemmal junctions. These results indicate that the R1086H MH mutation in α1S enhances RyR1 sensitivity to activation by both endogenous (voltage sensor) and exogenous (caffeine) activators.

AB - Malignant hyperthermia (MH) is an inherited pharmacogenetic disorder caused by mutations in the skeletal muscle ryanodine receptor (RyR1) and the dihydropyridine receptor (DHPR) α1S-subunit. We characterized the effects of an MH mutation in the DHPR cytoplasmic III-IV loop of α1S (R1086H) on DHPR-RyR1 coupling after reconstitution in dysgenic (α1S null) myotubes. Compared with wild-type α1S, caffeine-activated Ca2+ release occurred at approximately fivefold lower concentrations in nonexpressing and R1086H-expressing myotubes. Although maximal voltage-gated Ca2+ release was similar in α1S- and R1086H-expressing myotubes, the voltage dependence of Ca2+ release was shifted ∼5 mV to more negative potentials in R1086H-expressing myotubes. Our results demonstrate that α1S functions as a negative allosteric modulator of release channel activation by caffeine/voltage and that the R1086H MH mutation in the intracellular III-IV linker disrupts this negative regulatory influence. Moreover, a low caffeine concentration (2 mM) caused a similar shift in voltage dependence of Ca2+ release in α1S- and R1086H-expressing myotubes. Compared with α1S-expressing myotubes, maximal L channel conductance (Gmax) was reduced in R1086H-expressing myotubes (α1S 130 ± 10.2, R1086H 88 ± 6.8 nS/nF; P < 0.05). The decrease in Gmax did not result from a change in retrograde coupling with RyR1 as maximal conductance-charge movement ratio (Gmax/Qmax) was similar in α1S- and R1086H-expressing myotubes and a similar decrease in Gmax was observed for an analogous mutation engineered into the cardiac L channel (R1217H). In addition, both R1086H and R1217H DHPRs targeted normally and colocalized with RyR1 in sarcoplasmic reticulum (SR)-sarcolemmal junctions. These results indicate that the R1086H MH mutation in α1S enhances RyR1 sensitivity to activation by both endogenous (voltage sensor) and exogenous (caffeine) activators.

KW - Calcium channel

KW - Excitation-contraction coupling

KW - Muscle disease

UR - http://www.scopus.com/inward/record.url?scp=4544330774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4544330774&partnerID=8YFLogxK

U2 - 10.1152/ajpcell.00173.2004

DO - 10.1152/ajpcell.00173.2004

M3 - Article

C2 - 15201141

AN - SCOPUS:4544330774

VL - 287

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 4 56-4

ER -